Overview
The goal of this clinical trial is to learn if adding an artificial intelligence (AI) application called to standard Behavioral Parent Training (BPT) helps families with children who have disruptive behavior problems. It will also help researchers understand if the app is easy to use and helpful for parents.
The main question it aims to answer is:
\- Is it feasible and acceptable for parents to use the AI app alongside their therapy sessions?
The secondary questions it aims to answer are:
- Does the app help reduce children's disruptive behaviors and irritability more than therapy alone?
- Does using the app help lower stress, anxiety, and depression levels for the parents?
Researchers will compare:
- Standard BPT: Parents receive 8 weekly group training sessions (online).
- BPT plus ParenteAI: Parents receive the same 8 weekly sessions plus 24/7 access to an AI virtual assistant for personalized support.
Participants will:
- Attend 8 weekly group training sessions.
- Complete surveys about their child's behavior and their own well-being at baseline, after group training sessions 4 and 8, and 3 and 6 months after finalizing the group training.
- If in the experimental group, use the ParenteAI app to get real-time coaching and support for managing their child's behavior at home.
- Provide feedback on their experience and satisfaction with the program.
Description
This study seeks to evaluate new ways to support families with children exhibiting disruptive behavior problems, one of the leading causes of referral to mental health services. Although Behavioral Parent Training (BPT) has proven to be a highly effective treatment, many children do not receive adequate care due to a lack of resources and overstretched services. Therefore, this project explores whether the use of the AI-based application can increase the efficacy and accessibility of BPT.
Objectives: The primary objective is to examine the feasibility of adding the AI app to group-based BPT (acceptability, utility, satisfaction, therapeutic alliance, and attendance).
As a secondary objective, the study will evaluate the clinical impact of the AI app in reducing disruptive behaviors and irritability in children, as well as decreasing symptoms of depression, anxiety, and stress in parents.
Design: This is a randomized controlled trial with two conditions: (A) a control group, which will receive 8 weekly sessions of BPT (online) followed by treatment as usual for 6 months; and (B) an experimental group, which will receive the same BPT plus continuous access to the ParenteAI app, offering automated and personalized support via a 24/7 virtual assistant. Group assignment will be randomized using balanced blocks.
Outcome Measures:
Primary: Acceptability, utility (TAI), satisfaction (NPS), therapeutic alliance (WAI-SR), attendance, and dropout rates.
Secondary: Disruptive behaviors (ECBI), irritability (ARI), parental symptoms of depression, anxiety, and stress (DASS-21), and general psychopathology (SDQ), in addition to sociodemographic data and clinical diagnoses. Qualitative assessments of the experience with ParenteAI will also be collected.
Eligibility
Inclusion Criteria:
- Being a primary caregiver with a child aged 5 to 12 years exhibiting disruptive behaviors (e.g., symptoms of ODD, CD, IED, ADHD, and/or unspecified behavioral problems).
- Having access to an electronic device and regular internet access.
- Stable concomitant intervention including medications throughout the study.
- Speak Spanish or Catalan language.
- Signed informed consent by parents or legal guardians of the child.
Exclusion Criteria:
- Having ASD as primary diagnosis.
- Psychosis, self-harming behaviors, severe mood disorder.
- Known Intelligent quotient \< 70
- Caregivers and/or children receiving any concurrent psychological treatment.
- No signing the informant consent.
